Compare Myopia Treatments
Evidence, fit, and follow-up
Short answer: MiSight, Stellest/HAL designs, DIMS spectacle lenses, orthokeratology, and low-dose atropine all have evidence. The safest comparison asks whether the study matches this child's age, baseline myopia, axial length, treatment burden, follow-up duration, and country availability.
Practical comparison
| Category | Strength | Watch-outs |
|---|---|---|
| Spectacle lenslets | Strong option when contacts are not preferred; growing RCT evidence including HAL and DIMS designs. | Wear time, exact product/version, and regulatory geography matter. |
| Soft myopia-control contacts | Useful for motivated children and families; MiSight has strong pediatric RCT evidence. | Requires lens handling, hygiene, and daily adherence. |
| Orthokeratology | Overnight correction with daytime freedom; useful for selected patients. | Requires careful fitting, infection-risk counseling, and follow-up. |
| Low-dose atropine | Dose-response evidence; can be used alone or as an add-on. | Side effects, rebound, concentration, compounding, and adherence must be tracked. |
| Combination therapy | Clinically relevant when response is inadequate on monotherapy. | Combination evidence is less uniform; document why therapy was added or changed. |
Evidence applicability checklist
- Age: Pediatric evidence should not be automatically stretched to young adults.
- Baseline SER and AL: Results from mild-to-moderate cohorts may not transfer to very high myopia.
- Endpoint: Prefer axial-length outcomes when evaluating structural progression.
- Duration: Multi-year follow-up is stronger than short-term biometric change.
- Adherence and tolerability: Poor wear time or drop adherence can look like biologic treatment failure.
- Regulatory status: Indications and availability vary by country.
What to document at each visit
For a clinically useful record, document current treatment, start date, adherence, tolerability, axial-length change, SER change when available, reason for any switch or add-on, and the planned follow-up interval.
Compare outcomes inside MyopiaTracker
Use patient age, axial length, treatment history, and follow-up interval to generate a clinician-readable longitudinal summary.
Open MyopiaTracker →Educational only. MyopiaTracker supports clinical judgment and does not diagnose, prescribe, or replace examination by a qualified clinician.